Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman

Bladder cancer is the fourth most common malignancy in men and ninth most in woman. Most bladder cancers are urothelial, and the neuroendocrine sub-types make up 0.5–1.0% of cases. Here we present a 70-year-old female with poorly differentiated small cell carcinoma of the bladder who complains of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarver, Jordan, Memo, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577451/
https://www.ncbi.nlm.nih.gov/pubmed/34786346
http://dx.doi.org/10.1016/j.eucr.2021.101923
_version_ 1784596062340644864
author Sarver, Jordan
Memo, Mark
author_facet Sarver, Jordan
Memo, Mark
author_sort Sarver, Jordan
collection PubMed
description Bladder cancer is the fourth most common malignancy in men and ninth most in woman. Most bladder cancers are urothelial, and the neuroendocrine sub-types make up 0.5–1.0% of cases. Here we present a 70-year-old female with poorly differentiated small cell carcinoma of the bladder who complains of an extensive history of gross hematuria. She was started on a neoadjuvant chemotherapy regimen of 21-day Etoposide with Carboplatin and radical cystectomy. More work needs to be done when it comes to the best treatment method for this rare cohort of patients.
format Online
Article
Text
id pubmed-8577451
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85774512021-11-15 Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman Sarver, Jordan Memo, Mark Urol Case Rep Oncology Bladder cancer is the fourth most common malignancy in men and ninth most in woman. Most bladder cancers are urothelial, and the neuroendocrine sub-types make up 0.5–1.0% of cases. Here we present a 70-year-old female with poorly differentiated small cell carcinoma of the bladder who complains of an extensive history of gross hematuria. She was started on a neoadjuvant chemotherapy regimen of 21-day Etoposide with Carboplatin and radical cystectomy. More work needs to be done when it comes to the best treatment method for this rare cohort of patients. Elsevier 2021-10-29 /pmc/articles/PMC8577451/ /pubmed/34786346 http://dx.doi.org/10.1016/j.eucr.2021.101923 Text en Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Sarver, Jordan
Memo, Mark
Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
title Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
title_full Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
title_fullStr Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
title_full_unstemmed Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
title_short Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman
title_sort small-cell neuroendocrine tumor of the bladder: a rare disease in a low-risk woman
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577451/
https://www.ncbi.nlm.nih.gov/pubmed/34786346
http://dx.doi.org/10.1016/j.eucr.2021.101923
work_keys_str_mv AT sarverjordan smallcellneuroendocrinetumorofthebladderararediseaseinalowriskwoman
AT memomark smallcellneuroendocrinetumorofthebladderararediseaseinalowriskwoman

Ejemplares similares